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Abstract
Background: The aim of this study was to determine the prevalence and severity of dry eye syndrome in a group
of Mexican residents of different surgical specialties.
Methods: A cross-sectional descriptive study where the residents were studied using the Ocular Surface Disease
Index, together with diagnostic tests for dry eye syndrome, such as tear breakup time, Oxford Schema, Schirmer’s
test I, and meibomian gland dysfunction testing. Statistical analyses were performed by Pearson’s chi-squared test
for categorical variables and student’s t-test for quantitative variables. Any P value < 0.05 was considered statistically
significant.
Results: One hundred and twenty-three residents were included (246 eyes); 90 (73 %) were male and 33 (27 %)
were female. The mean age was 27.8 ± 2.1 years. A higher number of residents with dry eye syndrome was found
in the cardiothoracic surgery (75 %) and otorhinolaryngology (71 %) specialties; 70 % of them reported ocular
symptoms, with teardrop quality involvement in >50 % of them.
Conclusions: We found a prevalence of 56 % for mild-to-moderate/severe stages of the condition. Their presence
in the operating room predisposes surgical residents to dry eye syndrome because of environmental conditions.
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Background
Dry eye syndrome (DES) is recognized as a growing
public disease and is one of the most frequent causes of
ophthalmological consultation [1, 2]. According to the
International Dry Eye Workshop (DEWS) 2007, DES is
defined as a multifactorial disease of the tears and ocular
surface that results in symptoms of discomfort, visual
disturbance, and tear-film instability, with potential
damage to the ocular surface. It is accompanied by in-
creased osmolarity of the tear film and inflammation of
the ocular surface [1, 3–6].
DES affects millions of people worldwide (10–20 % of
the population), with a negative effect on their quality
of life [7].
DES results in dryness of the conjunctiva and cornea
because of decreased function of the tear and rapid
evaporation. These patients typically have damage of the
ocular surface epithelium and a deficiency in lacrimal se-
cretion, with chronic ocular irritation symptoms [8].
They complain mainly of a persistent dry eye sensation,
grittiness, ocular irritation, pain, tingling, foreign body
sensation, and visual disturbances [1, 4, 9, 10], which
affect their ability to work, read, use a computer, and
drive at night [4, 11]. Several studies have demonstrated
that in the presence of DES, either mild or severe, the
quality of life is diminished [4, 5, 12], to a level that is
comparable with the quality of life of patients undergo-
ing dialysis, severe angina, and hip fracture [5, 13].
There is an increase in the prevalence of DES in relation
to the number of working hours spent using a digital de-
vice, which is significant among individuals who are ex-
posed for 2–4 h per day [11, 14].
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The Women’s Health Study (WHS) and the Physicians’
Health Study (PHS), which were performed in the North
American population, estimated that about 4.61 million
Americans aged 50 years or older had DES, among whom
3.23 million were female and 1.68 million were male. Ac-
cording to the WHS, there is a higher prevalence of severe
symptoms and/or DES in Hispanic and Asian women
compared with Caucasians [7]; moreover, Ellwein et al.
found an increase of 57.4 % in the incidence rate of DES
per 100 beneficiaries of medical services, from 1.22 in
1991 to 1.92 in 1998. The importance of DES in public
health is given by the high prevalence of this disease in the
late-adulthood age group [15].
There is currently no data about the prevalence of dry
eye syndrome in healthcare personnel. Residents of sur-
gical specialties are exposed to risk factors that condition
them to the development of ocular symptoms, because
most of their training occurs inside the operating room
(OR), where the ventilation environment is enclosed and
the accuracy of the procedures to be performed as well
as the use of a microscope require greater concentration
and fixation on details, which decreases the blink rate,
causing damage to the ocular surface. As a consequence,
the presence of trigger factors affects the performance of
the physician-in-training because of how it impacts vis-
ual function and general welfare. Therefore, the purpose
of this study was to determine the prevalence of DES
in residents of the surgical branches of the Specialty
Hospital, Western National Medical Center.
Methods
A cross-sectional descriptive study in medical residents of
the different surgical branches of the Specialties Hospital,
Western National Medical Center, Mexican Institute of So-
cial Security, was performed from February through De-
cember 2014. The surgical specialties assessed were
angiology, cardiothoracic surgery, general surgery, colo-
proctology, neurosurgery, ophthalmology, oncological sur-
gery, otorhinolaryngology, traumatology and orthopedics,
and urology. Surgical residents of any year participated in
this study. The environmental conditions of the OR to
which residents were exposed, had a 64–75 °F room
temperature, and 55 % humidity.
The Ocular Surface Disease Index (OSDI) questionnaire
about associated risk factors was administered, as well as
diagnostic tests such as tear breakup time (TBUT), Oxford
Schema, Schirmer’s test I, and meibomian gland dysfunc-
tion testing. All residents were requested to agree to par-
ticipate in the study with a written informed consent.
Ocular surface disease index (OSDI)
The OSDI questionnaire was used to measure DES based
on three symptomatic subscales, referring to the week prior
to the implementation of the questionnaire. The possible
answers were: always, almost always, half the time, some-
times, and never. The scales evaluated were ocular dis-
comfort, functionality, and environmental factors. A
sum score on a 0–100 scale was obtained and classified
as: normal (0–12), mild (13–22), moderate (23–32), or
severe (33–100).
Questionnaire about risk factors
This questionnaire included data about sex, age, surgical
residency and current year, ocular and systemic diseases,
allergies, use of contact lenses, medication, hormonal
contraceptives, smoking, makeup use, and average hours
per day spent in the OR. In addition, the daily time spent
in the OR during a working day of 8 h and 24 h on-call
duty was evaluated; the use of a microscope for surgical
procedures and its average daily use (0–2 h, 2–4 h, and
>4 h) were also assessed.
Slit lamp biomicroscopy
Tear breakup time (TBUT)
TBUT was defined as the interval between the last
complete blink and the appearance of the first dry spot. A
sterile fluorescein strip (1 mg Fluorescein Sodium Oph-
thalmic strip, USP BioGlo™ Sterile Strips, HUB Pharma-
ceutics LLC, Rancho Cucamonga, CA) was placed in the
lower tarsus, and the resident was asked to blink several
times loosely 10 s after the instillation of fluorescein. The
slit lamp was set to a 10× magnification using a cobalt
blue light filter. A TBUT >10 s was defined as normal, and
a TBUT ≤10 s was defined as dry eye.
Assessment of ocular surface damage by staining—Oxford
schema
Using the Oxford Schema, which was validated by the
DEWS 2007, staining was represented by a dotted line in
a series of panels (A–E). Another strip of fluorescein was
used for this test; it was instilled with a drop of saline solu-
tion, the excess was removed, and it was placed in the
lower tarsal conjunctiva by pulling the lower eyelid. The
same procedure was used in both eyes. Staining was
evaluated under a cobalt blue light filter; to evaluate
the cornea, the upper lid was lifted to include the total
area of the cornea.
Schirmer’s test I
The test consisted of a drop instillation of 0.5 % tetracaine
hydrochloride ophthalmic solution with a 2-min waiting
time before the test. After wiping out the excess tear, we
proceeded to the placement of a Schirmer’s strip at the
junction of the lateral 1/3 and medial 2/3 of the lower lid
margin. Slow eyelid movements were allowed during the
procedure. Moisture was considered normal if the strip
was moistened over 10–30 mm, and hyposecretion was
considered in cases of strip moistening less than 10 mm.
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Meibomian gland dysfunction testing
Gland dysfunction was registered using a test validated by
The International Workshop on Meibomian Gland Dys-
function (2011). Finger pressure was applied to the nasal
third of each eye’s lower lid. Meibomian gland secretion,
or “meibum”, quality was assessed in each of the 8 glands
of the central third of the lower lid, on a 0–3 scale for
each gland: 0 = clear meibum; 1 = cloudy meibum; 2 =
cloudy with debris (granular); 3 = thick, like toothpaste.
The expressibility of the meibum was assessed from 5
glands: 0 = all glands were expressible; 1 = 3–4 glands were
expressible; 2 = 1–2 glands were expressible; 3 = no glands
were expressible. Gland dysfunction was classified accord-
ing to the score obtained:
Stage 1 =minimally altered secretions: grade >2 – <4;
expressiveness: 1.
Stage 2 =moderately altered secretions: grade >4 – <8;
expressiveness: 1.
Stage 3 =moderately altered secretions: grade >8 – <13;
expressiveness: 2.
Stage 4 = severely altered secretions: grade >13;
expressiveness: 3.
Statistical analysis and data processing
The data were captured in a database and were analyzed
using the SPSS software, version 22.0 (IBM, Armonk,
NY, 2013). The prevalence and range of the independent
variable was estimated, with a confidence interval of
95 %. Statistical analyses were performed by Pearson’s chi-
squared test for categorical variables and Student’s t-test
for quantitative variables. Any P value < 0.05 was consid-
ered statistically significant.
Sample size
Sample size for cross-sectional studies was assessed con-
sidering an alpha of 0.05 and a beta of 0.20 using Stalcalc
in Epi Info™, version 6.0 (Atlanta: Centers for Disease
Control and Prevention; 1994), in which it was estimated
to find DES in 30 % of the residents of the surgical area,
where 125 residents were required. The confidence level
was 95 %, and the power was 80 %.
Results
One hundred and twenty-five residents (250 eyes) who
met the established criteria were assessed. Two residents
were excluded for presenting ocular disease during the
previous week, leaving a total of 123 residents (246 eyes),
of whom 90 (73 %) were male and 33 (27 %) were female.
The mean age was 27.8 ± 2.1 years. Two physicians out-
side of the study conducted the Schirmer’s I test and the
TBUT. Inter-observer variation coefficients for the mea-
surements were evaluated in 123 residents for both tests,
resulting in 1.3 % and 1.2 %, respectively.
The prevalence of DES was higher in the female popula-
tion (22, 67 %) than it was in the male population (47,
52 %). Based on the OSDI, 56 % of the assessed residents
presented DES and 44 % were at a normal stage. Among
them, 21 % had mild, 18 % had moderate, and 17 % had
severe ocular symptoms. Of the 11 surgical specialties
evaluated, cardiothoracic surgery (75 %) and otorhino-
laryngology (71 %) presented a higher number of resi-
dents with a positive OSDI test (either mild, moderate,
or severe).
Among the four diagnostic tests applied, the TBUT test
showed that the quality of the tear was affected in more
than 50 % of the evaluated eyes: the TBUT was <10 s in
57 % of the residents. A significant difference was found
in the first and seventh year of residency (P = 0.008;
P = 0.01, respectively). According to the Oxford Schema,
76 % of the residents were classified as grade 0, whereas
the remaining 24 % were grade I (slight staining of the
ocular surface). Residents in their fourth year showed a
significant difference (P < 0.001). No grade II, III, IV, or V
conditions were observed. The results of TBUT and
Oxford Schema testing in relation to chronic eye dis-
ease, use of contact lenses, refractive surgery, risk fac-
tors, use of makeup, and use of a microscope are listed
in Table 1.
In contrast, in the Schirmer’s test I, 100 % of eyes exhib-
ited normal parameters. Meibomian gland dysfunction
testing reported that 77 % of the residents were in stage 1
(normal), whereas the remaining 23 % of the residents were
in stage 2 (mild meibomian gland dysfunction). According
to year of residency, a significant difference was found in
first and fourth year residents (P = 0.003; P = 0.001, respect-
ively). No eyes were classified as being in stages 3 or 4.
Regarding risk factors, there was a significant difference
in dysfunction of the meibomian glands in smokers
(P = 0.009). The results of the Schirmer’s and meibomian
gland dysfunction tests in relation to chronic eye disease,
use of contact lenses, refractive surgery, risk factors, use of
makeup, and use of a microscope are listed in Table 2.
Fifty-four residents (44 %) mentioned the use of a
microscope during surgery, whereas 56 % (69) did not
require a microscope. OSDI ranking was obtained for
those who used a microscope: 37 % (20) presented a
normal OSDI test, and 63 % (34) exhibited mild, moder-
ate, or severe OSDI grading.
Regarding year of residency, first-year residents had a
higher percentage of DES according to OSDI (76 % res-
idents affected), followed by sixth-year residents (67 %),
second-year residents (57 %), and third-year residents
(56 %). When asked about eye symptoms (sensitivity to
light, grittiness, eye pain, and blurred or poor vision)
during the last year of residency, as well as their pres-
ence during surgery, on-call, or microscope use, 71 %
(87) of the residents reported having them.
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The relationship between operating hours in an 8 h
working day and OSDI score was evaluated: >50 % of resi-
dents who operated an average of 0–6 h per day were
positive for DES. According to operating hours on a 24 h
on-call shift, >55 % of those with a surgery time of 0–2 h
and >4 h presented a positive OSDI score for DES.
Discussion
It is well known that DES is a growing disease, affecting
approximately 10–20 % of the population worldwide [1].
In the population over 50 years of age, the prevalence of
DES ranges from 5 % to 30 %; however, by 2050, the es-
timated prevalence will reach up to 100 % [2]. In this
Table 1 Tear breakup time and Oxford Schema in relation to risk factors
Variable Tear breakup time <10 s Tear breakup time >10 s P value Oxford Schema 0 Oxford Schema 1 P value
1st year of residency 33 (79 %) 9 (21 %) 0.008 28 (67 %) 14 (33 %) 0.06
2nd year of residency 34 (63 %) 20 (37 %) 0.88 45 (83 %) 9 (17 %) 0.54
3rd year of residency 32 (47 %) 36 (53 %) 0.14 58 (85 %) 10 (15 %) 0.29
4th year of residency 23 (68 %) 11 (32 %) 0.23 22 (65 %) 12 (35 %) <0.001
5th year of residency 7 (32 %) 15 (68 %) 0.02 19 (86 %) 3 (14 %) 0.33
6th year of residency 10 (56 %) 8 (44 %) 0.91 16 (89 %) 2 (11 %) 0.27
7th year of residency 1 (12 %) 7 (88 %) 0.01 8 (100 %) 0 (0 %) 0.16
Chronic eye disease 43 (58 %) 31 (42 %) 0.80 62 (84 %) 12 (16 %) 0.29
Contact lenses 13 (81 %) 3 (19 %) 0.04 9 (56 %) 7 (44 %) 0.02
Refractive surgery 19 (68 %) 9 (32 %) 0.21 24 (86 %) 4 (14 %) 0.39
Allergies 41 (66 %) 21 (34 %) 0.09 52 (84 %) 10 (16 %) 0.34
Smoking 21 (50 %) 21 (50 %) 0.32 32 (76 %) 10 (24 %) 0.53
Hormonal contraceptives 9 (56 %) 7 (44 %) 0.10 14 (87 %) 2 (13 %) 0.51
Makeup use 41 (71 %) 17 (29 %) 0.66 51 (88 %) 7 (12 %) 0.04
Makeup use, 0–12 h 23 (68 %) 11 (32 %) 0.54 34 (100 %) 0 (0 %) 0.001
Makeup use, 12–24 h 18 (75 %) 6 (25 %) 0.54 17 (71 %) 7 (29 %) 0.001
Microscope use 73 (68 %) 35 (32 %) 0.10 84 (78 %) 24 (22 %) 0.003










1st year of residency 0 (0 %) 42 (100 %) 27 (64 %) 15 (36 %) 0.003
2nd year of residency 0 (0 %) 54 (100 %) 42 (77 %) 12 (23 %) 0.83
3rd year of residency 0 (0 %) 68 (100 %) 53 (78 %) 15 (22 %) 0.90
4th year of residency 0 (0 %) 34 (100 %) 23 (68 %) 11 (32 %) 0.001
5th year of residency 0 (0 %) 22 (100 %) 20 (91 %) 2 (9 %) 0.10
6th year of residency 0 (0 %) 18 (100 %) 17 (94 %) 1 (6 %) 0.47
7th year of residency 0 (0 %) 8 (100 %) 8 (100 %) 0 (0 %) 0.13
Chronic eye disease 0 (0 %) 74 (100 %) 61 (82 %) 13 (18 %) 0.20
Contact lenses 0 (0 %) 16 (100 %) 15 (94 %) 1 (6 %) 0.08
Refractive surgery 0 (0 %) 28 (100 %) 22 (79 %) 6 (21 %) 0.85
Allergies 0 (0 %) 62 (100 %) 47 (76 %) 15 (24 %) 0.075
Smoking 0 (0 %) 42 (100 %) 26 (62 %) 16 (38 %) 0.009
Hormonal contraceptives 0 (0 %) 16 (100 %) 8 (50 %) 8 (50 %) 0.013
Makeup use 0 (0 %) 58 (100 %) 27 (47 %) 31 (53 %) 0.09
Makeup use, 0–12 h 0 (0 %) 34 (100 %) 21 (62 %) 13 (38 %) 0.025
Makeup use, 12–24 h 0 (0 %) 24 (100 %) 6 (25 %) 18 (75 %) 0.025
Microscope use 0 (0 %) 108 (100 %) 73 (68 %) 35 (32 %) 0.47
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sense, the mean age observed in the present study was
27.8 years, and 56 % of the residents presented DES in a
mild, moderate, or severe form, according to the OSDI.
This fact proves the great epidemiological relevance of
the development of DES at a younger age than reported
previously. In the study published by Sahai et al., a peak
of prevalence of DES was reported within the 31–40-
year-old group, which was attributed to the type of en-
vironmental exposure [2].
Several studies reported a higher prevalence of DES in
females [2, 7], similar to the results of this study, with a
prevalence of 67 % (22). This difference can be explained
based on the relationship between the menstrual cycle
phase and the presence of ocular symptoms [6]. In physio-
logical doses, estrogens serve as support for the function
of the lacrimal gland and the preservation of a healthy
ocular surface at an early age; however, in high doses or in
combination with hormone supplements, they can be
harmful and/or induce inflammation [16]. Forty-eight per-
cent of the women surveyed reported using some type of
hormonal contraceptive, among whom 75 % presented
DES, with lacrimal gland dysfunction in >50 % of them.
Another risk factor associated with the female sex is the
use of makeup, because of the changes caused in the
structure of the tear film by migration to the ocular sur-
face [17], which is in keeping with our findings that 71 %
of female residents showed tear-film instability and that
53 % exhibited mild meibomian gland dysfunction.
A study conducted by Sahai et al. found that patients
with a refractive error had a higher prevalence of DES
than did emmetropes; however, the cause of this
phenomenon was not determined in that study [2]. This
prevalence is similar to the one found in residents who
reported either ocular conjunctivitis or ametropia, with a
positive OSDI for DES. In our study, 71 % of the popula-
tion that had undergone refractive surgery presented a
positive OSDI for DES, among whom 68 % presented a
TBUT of <10 s. This is comparable with the fact that
88 % of the residents who wore contact lenses had DES
according to the OSDI test, which is consistent with pre-
vious reports in the literature [4, 18, 19]. However, re-
garding cigarette consumption, this study contrasts with
the literature, as the presence of DES was not found in
residents who smoked. Smoking is a risk factor for DES
because it increases ocular symptoms by altering the tear
evaporation rate [20].
In the study conducted by Smedbold et al., who assessed
nurses working in different departments of geriatric hospi-
tals with the aim of studying the relationship between the
environment and signs of eye irritation, it was found that,
in high-temperature environments with low humidity,
the tear evaporation rate was increased, causing in-
stability of the tear film [7, 21]. No additional studies of
the presence of DES in health professionals working in
hospital environments were found. However, DES has
been studied well in office workers who use any digital
device, with an increased prevalence in those exposed to
them for 2–4 h a day [11, 14, 18]. Uchino et al. reported
that a period >4 h a day working in front of a digital de-
vice increases the expression of severe symptoms of DES,
with significant clinical relevance (P < 0.001) [11]. Seventy
percent of respondents in the study presented ocular
symptoms over the last year. Among them, more than half
presented a positive OSDI test for DES (P <0.001). More-
over, 72 % presented ocular symptoms during surgery,
among whom 77 % had DES (P = 0.002). In addition, 67 %
of these individuals presented symptoms during an on-call
shift, more than half of whom presented a positive OSDI
test for DES (P <0.001).
Environmental irritants can be associated with the “sick
building syndrome” (i.e., a disease caused by irritants found
in the workplace, volatile organic compounds, and low-
humidity conditions), in which there is an eye and mu-
cous membrane irritation, causing an unstable tear film
in office workers [22, 23]. It is well known that the cli-
mate has an influence on the clinical diagnostic dry eye
tests. The present study was conducted in Guadalajara,
Jalisco, Mexico with an average temperature of 65 °F
(53–81 °F) that remains stable all year round, and a
temperature of 64–75 °F inside the OR.
The lack of reliable diagnosis due to a bedeviled as-
sessment of dry eye syndrome might be secondary to
poor diagnostic repeatability, which is manifested as
significant false-positive/negative rates, broad range of
variability, wide range of sensitivity and specificity, and
dependence on clinical conditions [24].
We may also consider anterior-segment optical coher-
ence tomography as a diagnostic tool, which evaluates
epithelial thickness and reveals abnormalities of the dy-
namic pattern of tears, even when the common lacrimal
tests appear to be normal [25].
Recently, tear osmolarity has been proposed as the gold
standard for DES, but there is still no consensus about its
use as the best diagnostic tool. Therefore, several diagnos-
tic modalities should be performed, such as diagnostic
tests and external examination, based on the patient’s
symptoms and medical history [1, 26].
We propose further comparative studies to assess
timing, quality, accuracy of procedures, and evaluation
to verify how DES negatively affects the performance of
the residents.
Conclusions
The presence of surgical residents in the OR renders them
susceptible to the development of DES because of the en-
vironmental conditions to which they are exposed, be-
cause of which causes ocular discomfort. This condition
affects the quality of life and performance of residents,
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because of the irritative symptoms, the modification of the
visual function, and the effects on general health and wel-
fare. Fifty-six percent of the residents surveyed presented
DES.
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